Targeting apoptosis signaling pathways in cancer therapy

Chinese Journal of Pathology

Volumn 38, Issue 9, 2009, Pages 639-642

  Cheng, Liang ^a   Wang, Xi ^a   Zhang, Jie ^a   Zhang, Shao Bo ^a   Zheng, Su Qin ^a   Zheng, Jie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 10; CASPASE 11; CASPASE 12; CASPASE 2; CASPASE 4; CASPASE 5; CASPASE 8; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN BCL 2; PROTEIN P53; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; CANCER RESEARCH; HUMAN; NONHUMAN; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; ENZYME ACTIVATION; FAS LIGAND PROTEIN; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 70350064760     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0529-5807.2009.09.019     Document Type: Review

References (21)

1. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer, 1972, 26(4):239-257.
2. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature, 2001, 411(6835):342-348. (Pubitemid 32467043)
3. Brown JM, Attardi LD. The role of apoptosis in cancer development and treatment response. Nat Rev Cancer, 2005, 5(3):231-237.
4. Denicourt C, Dowdy SF. Medicine. Targeting apoptotic pathways in cancer cells. Science, 2004, 305(5689):1411-1413.
5. Meiler J, Schuler M. Therapeutic targeting of apoptotic pathways in cancer. Curr Drug Targets, 2006, 7(10):1361-1369. (Pubitemid 44509700)
6. Ziegler DS, Kung AL. Therapeutic targeting of apoptosis pathways in cancer. Curr Opin Oncol, 2008, 20(1):97-103.
7. Marx J. Oncology. Recruiting the cell's own guardian for cancer therapy. Science, 2007, 315(5816):1211-1213.
8. Fesik SW. Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer, 2005, 5(11):876-885. (Pubitemid 41746032)
9. Bremer E, van Dam G, Kroesen BJ, et al. Targeted induction of apoptosis for cancer therapy= current progress and prospects. Trends Mol Med, 2006, 12(8):382-393. (Pubitemid 44164637)
10. Ghobrial IM, Witzig TE, Adjei AA. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin, 2005, 55(3):178-194. (Pubitemid 40826487)
11. Bartek J, Lukas J. Cell biology. Balancing life-or-death decisions. Science, 2006, 314(5797):261-262.
12. Hetz C, Bemasconi P, Fisher J, et al. Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRElalpha. Science, 2006, 312(5773):572-576.
13. Li L, Thomas RM, Suzuki H, et al. A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death. Science, 2004, 305(5689):1471-1474. (Pubitemid 39167668)
14. Rowinsky EK. Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents. J Clin Oncol, 2005, 23(36):9394-9407.
15. Zhang S, Zeng G, Kao C, et al. Fas-Fas ligand signaling pathway mediates an interleukin-12-induced rejection of a murine prostate tumor system. Prostate, 2002, 53(1):69-76. (Pubitemid 34966866)
16. Jiang J, Ulbright TM, Zhang S, et al. Fas and Fas ligand expression is elevated in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. Cancer, 2002, 95(2):296-300. (Pubitemid 34787595)
17. Su H, Bidère N, Zheng L, et al. Requirement for caspase-8 in NF-kappaB activation by antigen receptor. Science, 2005, 307(5714):1465-1468.
18. Sweeney C, Li L, Shanmugam R, et al. Nuclear factor-kappaB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate. Clin Cancer Res, 2004, 10(16):5501-5507.
19. Lopez-Beltran A, Maclennan GT, de la Haba-Rodriguez J, et al. Research advances in apoptosis-mediated cancer therapy: a review. Anal Quant Cytol Histol, 2007, 29(2):71-78. (Pubitemid 46649484)
20. Vousden KH. Apoptosis. p53 and PUMA: a deadly duo. Science, 2005, 309(5741):1685-1686.
21. Teodoro JG, Parker AE, Zhu X, et al. p53-mediated inhibition of angiogenesis through up-regulation of a collagen prolyl hydroxylase. Science, 2006, 313(5789):968-971. (Pubitemid 44267388)